Search results
Salt for migraine: Research, migraine treatment, and more
Medical News Today· 6 days agoResearch into the effect of salt on migraine is ongoing. Migraine is a type of headache disorder...
What Causes Postpartum Headaches, and Can You Prevent Them?
Parents via Yahoo News· 4 hours agoHeadaches are common after giving birth. Learn about postpartum headaches, including causes, ...
Positive response to Botox injection predicts better results of migraine surgery
Medical Xpress· 6 days agoJanis, MD, of The Ohio State University Wexner Medical Center, Columbus. Peripheral nerve decompression, or trigger point deactivation surgery, has become an established treatment< ...
Zomig interactions: Other medications, alcohol, and more
Medical News Today· 1 day agoZomig (zolmitriptan) is a brand-name oral tablet and nasal spray. It’s prescribed to treat migraine...
Tosymra and dosage: Strength, form, when to use, and more
Medical News Today· 6 days agoTosymra (sumatriptan) is a brand-name drug that’s prescribed to treat migraine with or without aura...
Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
Zacks via Yahoo Finance· 7 hours agoAxsome’s key pipeline candidates include AXS-07, AXS-12 and AXS-14, which target multiple central...
Are Pressure Headaches Before A Storm A Real Thing?
IFLScience· 1 day agoIf you’ve ever noticed yourself getting a headache just before a storm hits, it might not be a coincidence. In fact, weather conditions are commonly...
AEON Biopharma's migraine treatment fails to meet trial goals By Investing.com
Investing.com· 4 days agoAEON Biopharma, Inc. (NYSE: AEON), a clinical-stage biopharmaceutical company, reported today that...
PPIs Tied to Migraine, Other Severe Headache Types
Medscape· 5 days agoProton pump inhibitors (PPIs), which are used to control acid reflux, are associated with an increased risk for migraine and other severe headache types,...
Newly Listed Migraine-Focused AEON Biopharma Stock Plunges On Friday - Read Here Why - AEON...
Benzinga· 4 days agoFriday, AEON Biopharma Inc AEON reported that the preliminary top-line results from its planned...